Stock Analysis

Meinian Onehealth Healthcare Holdings (SZSE:002044) sheds CN¥700m, company earnings and investor returns have been trending downwards for past five years

SZSE:002044
Source: Shutterstock

Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed. For example the Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) share price dropped 62% over five years. That's not a lot of fun for true believers. And some of the more recent buyers are probably worried, too, with the stock falling 41% in the last year. Furthermore, it's down 24% in about a quarter. That's not much fun for holders.

If the past week is anything to go by, investor sentiment for Meinian Onehealth Healthcare Holdings isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

Check out our latest analysis for Meinian Onehealth Healthcare Holdings

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During five years of share price growth, Meinian Onehealth Healthcare Holdings moved from a loss to profitability. That would generally be considered a positive, so we are surprised to see the share price is down. Other metrics might give us a better handle on how its value is changing over time.

We don't think that the 0.5% is big factor in the share price, since it's quite small, as dividends go. Revenue is actually up 5.5% over the time period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

earnings-and-revenue-growth
SZSE:002044 Earnings and Revenue Growth June 21st 2024

We know that Meinian Onehealth Healthcare Holdings has improved its bottom line lately, but what does the future have in store? You can see what analysts are predicting for Meinian Onehealth Healthcare Holdings in this interactive graph of future profit estimates.

A Different Perspective

While the broader market lost about 14% in the twelve months, Meinian Onehealth Healthcare Holdings shareholders did even worse, losing 41% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 10% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. Before deciding if you like the current share price, check how Meinian Onehealth Healthcare Holdings scores on these 3 valuation metrics.

We will like Meinian Onehealth Healthcare Holdings better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.